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limiting and how to optimize the plan. Without this 
approach, there was an increase risk of severe, even fatal 
esophagus toxicity for the patient. 
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Purpose/Objective: In England in 2012/2013, there was a 
strong Government drive to increase the availability of 
IMRT/VMAT treatment for appropriate patient groups. Up to 
September 2013, prostate and seminal vesicle patients (PSV) 
at this centre were treated with a 3 field forward planned 
IMRT technique (fpIMRT) using 10MV photons (with target and 
OAR doses based on the CHHiP trial using a 3 dose level 
target PTV1, 2 and 3). This was replaced with a 6MV single 
arc VMAT technique. In both cases, treatment delivery was 
with Elekta Synergy accelerators fitted with MLCi (1cm leaf 
width). This investigation looked at the organ at risk (OAR) 
doses achieved using both techniques. In introducing this new 
technique, the minimum target dose to PTV1 (PSV + a 
uniform margin of 1cm) was also increased in line with 
another UK department who provided VMAT implementation 
mentoring. This audit assessed the effect of the treatment 
technique change along with PTV1 dose escalation and 
identified whether the acute side effects seen during 
treatment were affected by this technique and dose change. 
Materials and Methods: Philips Pinnacle V9.8 is routinely 
used to contour and plan all PSV patients. DVH analysis was 
performed to extract OAR doses and PTV doses for 39 
patients who were planned using the fpIMRT technique and 
49 patients planned using the VMAT technique. Microsoft 
Excel 2010 was used to collate and analyse the data. The 
RTOG scoring system was used during treatment to assess 6 
common acute side effects for this group of patients. 
Results: All dose constraints were met consistently met using 
a forward planned technique. However the introduction of 
VMAT planning allowed an escalation to the achievable PTV1 
minimum dose within those same dose constraints. The RTOG 
scores during treatment for six common acute side effects for 
this group of patients showed that whilst the difference in 
technique has not decreased the side effects seen by a 
statistically significant amount, the average score for each 
side effect were lower for the patients treated with VMAT, 
even with the higher dose to PTV1. 
The low dose bath effect to the rectum of the VMAT planning 
technique is evident in the analysis of the dose constraints, 
with the average V30Gy at 76.2% and the average V40Gy at 
64.6%, compared with V30Gy: 55.8%, V40Gy: 43.4% for 
fpIMRT. These dose constraints were not classified as 
mandatory in the CHHiP clinical trial or in this department's 
clinical protocol. The mandatory high dose (65Gy, 70Gy, 
74Gy) constraints demonstrate a reduction in the amount of 
rectum within these dose regions of the prostate treatment 
with the implementation of VMAT. 
 
Conclusions: Implementation of a VMAT technique for the 
treatment of PSV has resulted in an increase of dose 
uniformity of the PTVs by increasing the achievable minimum 
PTV1 dose and reducing the high dose level received by the 
rectum. Further work will investigate whether there is scope 
within those same OAR constraints to escalate PTV doses 
further if clinically rquired. 
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Purpose/Objective:  tolerance and toxicity of adiuvant 
exclusive vaginal High Dose Rate Brachytherapy (HDR_BT) in 
patients with endometrial cancer. 
Materials and Methods: A total of 30 patients (pts), median 
age 70 years old, were treated by postoperative HDR vaginal 
cuff Brachytherapy. Patients underwent hysterecomy for 
endometrial cancer. Staging and grading according FIGO were 
8-IA, 18 IB, 3 II, 1-IIIA; 2-G1, 18-G2, 10-G3. HDR-BRT was 
performed using vaginal cylindrical applicators applied to the 
patients who received five fractions of 600cGy to a total dose 
of 3000 cGy prescribed to the 0.5 from the applicator's 
surface. Computed Tomography (CT) simulation was 
performed with CT slices thickness of 5 mm. Proximal 3-3.5 
cm of the vagina were treated. Bowels are more than bladder 
very radiosensitive and so to prevent bowels toxicity, all 
patients were asked to consume from 250 ml to 400 ml of 
water 30 minutes before CT scan and before treatment and 
empty rectum by means a selfie applied rectal enema. Acute 
and late Gastrointestinal (GI) and Genitourinary (GU) 
toxicities were investigate according RTOG Toxicity scale. 
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During treatment patients received supportive cares as 
lactospore and probiotic diet supplement, and at the end of 
treatment supportive care as vaginal ovules were suggest to 
manage a vaginal discomfort or mucosal toxicity. At every 
follow up, patients underwent to gynaecologic exam and 
urynalysis at 1month after treatmentand every 6 months 
later. 
Results: 15 pts reported acute GU toxicity: 6 G1, 9 G2 and 2 
pts developed vaginal stenosis. GI acute toxicity was 
observed in 10 pts as G1, no G2-G3 was observed. One 
patient experienced late toxicity GU G1, and 2 pts had 
vaginal stenosis. No GI late toxicity was observed. 
Conclusions: HDR-BRTwith vaginal cylinder treatment is 
feasible and well tolerate, specially with a low GI toxicity, 
but to realize a g good treatment with a lower as possible 
toxicity in GU and to preserve bowels keeping a low toxicity 
seem to be very important the fullness of bladder. Empty 
bladder seem to have a worse impact on GI toxicity. Vaginal 
stenosis was the main disorder we observed in a long term 
follow up, so the use of vaginal dilatators is recommended to 
prevent vaginal stenosis.  
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Purpose/Objective: The aim of the study is to investigate 
dosimetric aspects in left breast radiotherapy when the 
internal mammary chains (IMC), the three levels of axillary 
lymph nodes (ALN) and sopraclavear lymph nodes (SLN) are 
included in the radiation target volume beside the breast 
alone. Recent studies focused their attention on the use of 
more complex irradiation techniques, as IMRT, in order to 
reduce the OAR toxicity. The present study compares the 
dose distributions obtained with two different irradiation 
techniques, in 4 scenarios with increasing complexity of 
target volume definition.  
Materials and Methods: CT scans from one female patient 
with left breast cancer were considered. The patient was 
immobilized with wing system in supine position and in free 
breath condition. 
Four different planning target volumes (PTVi) scenarios were 
created, based on ESTRO Guidelines, as following: 
PTV1: breast  
PTV2: breast plus IMC 
PTV3: breast plus IMC, 3rd axillaries level and SLN  
PTV4: breast plus ALN levels.  
CRT was planned for each PTVi scenarios with Pinnacle3 TPS 
using multiple 6MV photon beams delivered with Artiste 
Linac. Helical Tomotherapy (HT) plan parameters were: 
2.5cm field width, 0.287 pitch. A dose of 50 Gy in 25 
fractions was prescribed. Spinal Cord, heart, lungs, 
contralateral breast were drawn as OARs. Dose-volume 
constrains were set based on QUANTEC recommendations and 
toxicity data previously published in IMRT dosimetric studies. 
The performance of the different irradiation techniques were 
compared in terms of plan quality (PTV dose conformity and 
OAR constraints compliance). 
Results: Irrespective of scenario complexity, the goal of 95% 
of the prescribed dose to 100% of PTV was reached by TH. 
CRT, in particular for PTV4, showed worse quality coverage 
(90%-95% of prescribed dose).  
Mean dose (Dm) and volume percentage receiving 20 Gy (V20) 
for ipsilateral lung, Dm and V25 for heart, Dm and the 
maximum dose (Dmax) for contralateral breast were reported 
in table 1.  
We observed more advantage in HT plans for ipsilateral lung 
(especially for PTV4) and, at the same time, a slightly 
increase in heart and contralateral breast mean doses 
respect to CRT.  
Table 1 
 
 
Conclusions: This study proved that the use of more complex 
irradiation techniques can allow to better manage various 
extension of lymph nodes target volumes in breast cancer RT 
with a sensible spare of OARs. 
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Purpose/Objective: Field-in-field technique is applied to 
ameliorate the conventional planning with 2 tangential fields 
for adjuvant treatments of breast cancers. It is based on the 
use of additional smaller fields within the main ones, in order 
to improve different parameters of the treatment plan. 
Ideally, each of the smaller additional fields should be 
delivered in perfect alignment to the main one. We 
evaluated the alignment of field-in-field to the main field 
during the treatment. 
Materials and Methods: We analyzed patients treated with 
Field-in-field technique. Each patient underwent to 
evaluation of set-up error at 3 different time-points over the 
treatment by electronical portal image (EPI) on the 
conventional main fields (CMF). An additional EPI was 
performed on each field-in-field (FIF) at the moment of the 
FIF delivery during the treatment to record the specific 
misalignment reported at the moment of the delivery. Setup 
errors in millimeters were derived by the conventional EPI. 
The misalignment between the FIF and the CMF was derived 
by subtraction of respective setup errors. A statistical 
analysis of the significance of differences reported on 
treatment plans between tangential conventional (CTP) and 
